Promising Longevity Drugs
Exciting developments in longevity research reveal that SGLT2 inhibitors may surpass metformin in enhancing health span and reducing mortality. While metformin remains a popular choice for those managing prediabetes, biphosphonates are emerging as unexpected players in longevity, showing potential to decrease mortality rates despite their primary use for osteoporosis. The conversation highlights the evolving understanding of these drugs and their implications for human health.In this clip
From this podcast
The Doctor's Farmacy with Mark Hyman, M.D.
This Doctor Thinks They Have The Longevity Protocol To Prevent Disease | Nir Barzilai
Related Questions